Thiol modified mycolic acids
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Yn: Chemistry and Physics of Lipids, Cyfrol 172-173, Rhif July-August, 07.2013, t. 40-57.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Thiol modified mycolic acids
AU - Balogun, Mohammed O
AU - Huws, Enlli H
AU - Sirhan, Muthana M
AU - Saleh, Ahmed D
AU - Al Dulayymi, Juma'a R
AU - Pilcher, Lynne
AU - Verschoor, Jan A
AU - Baird, Mark S
N1 - Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
PY - 2013/7
Y1 - 2013/7
N2 - Patient serum antibodies to mycolic acids have the potential to be surrogate markers of active tuberculosis (TB) when they can be distinguished from the ubiquitously present cross-reactive antibodies to cholesterol. Mycolic acids are known to interact more strongly with antibodies present in the serum of patients with active TB than in patients with latent TB or no TB. Examples of single stereoisomers of mycolic acids with chain lengths corresponding to major homologues of those present in Mycobacterium tuberculosis have now been synthesised with a sulfur substituent on the terminal position of the α-chain; initial studies have established that one of these binds to a gold electrode surface, offering the potential to develop second generation sensors for diagnostic patient antibody detection.
AB - Patient serum antibodies to mycolic acids have the potential to be surrogate markers of active tuberculosis (TB) when they can be distinguished from the ubiquitously present cross-reactive antibodies to cholesterol. Mycolic acids are known to interact more strongly with antibodies present in the serum of patients with active TB than in patients with latent TB or no TB. Examples of single stereoisomers of mycolic acids with chain lengths corresponding to major homologues of those present in Mycobacterium tuberculosis have now been synthesised with a sulfur substituent on the terminal position of the α-chain; initial studies have established that one of these binds to a gold electrode surface, offering the potential to develop second generation sensors for diagnostic patient antibody detection.
KW - Antibodies/immunology
KW - Electrochemical Techniques
KW - Electrodes
KW - Humans
KW - Mycolic Acids/chemical synthesis
KW - Stereoisomerism
KW - Sulfhydryl Compounds/chemistry
KW - Tuberculosis/immunology
U2 - 10.1016/j.chemphyslip.2013.03.004
DO - 10.1016/j.chemphyslip.2013.03.004
M3 - Article
C2 - 23603063
VL - 172-173
SP - 40
EP - 57
JO - Chemistry and Physics of Lipids
JF - Chemistry and Physics of Lipids
SN - 0009-3084
IS - July-August
ER -